Home > Products > CD55 & CA9
> Anti-CD55 x Anti-CA9 Bispecific Antibody (IgG-IgG)
Anti-CD55 x Anti-CA9 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-123)
Anti-CD55 x Anti-CA9 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD55 and anti-CA9 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.
There are currently no customer reviews or questions for Anti-CD55 x Anti-CA9 Bispecific Antibody (IgG-IgG) (BSIG-123). Click the button below to contact us or submit your feedback about this product.